Favezelimab in Combination with Pembrolizumab in Patients with Heavily Pretreated Anti-PD-1-Refractory Classical Hodgkin Lymphoma: Updated Analysis of an Open-Label Phase 1/2 StudyJohn Timmerman,David Lavie,Nathalie A. Johnson,Abraham Avigdor,Peter Borchmann, Charalambos Andreadis,Ali Bazargan, Gareth P. Gregory,Colm Keane,Inna Tzoran,Vladan Vucinic,Pier Luigi Zinzani,Rachel Marceau West,Pallavi Pillai,Patricia Marinello,Alex F. HerreraBLOOD（2023）引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
